Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 35.18B | 32.68B | 31.10B | 27.81B | 25.77B | 26.38B |
Gross Profit | 7.95B | 7.15B | 6.80B | 6.67B | 6.38B | 6.41B |
EBITDA | 4.19B | 3.57B | 2.96B | 2.58B | 1.92B | 2.59B |
Net Income | 2.17B | 1.78B | 1.40B | 1.05B | 747.76M | 1.30B |
Balance Sheet | ||||||
Total Assets | 20.45B | 20.06B | 17.52B | 16.24B | 16.80B | 15.25B |
Cash, Cash Equivalents and Short-Term Investments | 6.44B | 5.92B | 5.07B | 4.91B | 5.02B | 4.69B |
Total Debt | 1.20B | 2.55B | 2.13B | 2.72B | 3.45B | 1.11B |
Total Liabilities | 7.18B | 8.05B | 7.09B | 6.79B | 7.39B | 6.52B |
Stockholders Equity | 13.21B | 11.95B | 10.38B | 9.40B | 9.37B | 8.70B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.21B | 1.51B | 1.68B | -796.40M | 3.12B |
Operating Cash Flow | 0.00 | 1.42B | 1.65B | 1.84B | -607.39M | 3.23B |
Investing Cash Flow | 0.00 | -233.18M | -360.39M | -9.40M | -612.07M | -114.37M |
Financing Cash Flow | 0.00 | -432.38M | -1.28B | -1.89B | 1.49B | -2.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥36.55B | 16.13 | 3.22% | 11.00% | 33.93% | ||
77 Outperform | ¥26.21B | 10.89 | 1.19% | 11.94% | 14.10% | ||
77 Outperform | ¥56.58B | 14.92 | 2.60% | 9.68% | -2.04% | ||
71 Outperform | ¥32.98B | 14.06 | 3.64% | 0.01% | 35.73% | ||
69 Neutral | ¥228.59B | 14.33 | 7.64% | 2.71% | 9.13% | 8.49% | |
67 Neutral | €32.98B | 12.67 | 7.79% | 5.12% | 2.87% | 4.34% | |
65 Neutral | ¥23.15B | 32.02 | 1.81% | 7.60% | -6.99% |